|
Diabetes, Vol 44, Issue 9 1038-1045, Copyright © 1995 by American Diabetes Association
Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin
K Rebrin, GM Steil, L Getty and RN Bergman
Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles 90033, USA.
Overproduction of glucose by the liver in the face of insulin resistance is
a primary cause of hyperglycemia in non-insulin-dependent diabetes mellitus
(NIDDM). However, mechanisms involved in control of hepatic glucose output
(HGO) remain less than clear, even in normal individuals. Recent results
have supported an indirect extrahepatic effect of insulin as the primary
locus of insulin action to restrain HGO. One suggested extrahepatic site is
the pancreatic alpha-cell. To examine whether insulin's extrahepatic site
is independent of the alpha-cells, HGO suppression was examined independent
of changes in glucagon secretion or insulin antagonism of glucagon action.
Euglycemic glucose clamps (n = 40) with somatostatin infusion were
performed in conscious dogs (n = 5). Paired experiments were conducted in
which insulin was infused either portally (1.2, 3.0, 6.0 pmol.min-1.kg-1)
or peripherally at half the portal infusion rate (0.6, 1.5, 3.0
pmol.min-1.kg-1). Additional zero and saturating portal-dose experiments
(100 pmol.min-1.kg-1) were also performed. For the paired experiments,
portal insulin infusion resulted in portal insulin concentrations
approximately two to three times higher than in the corresponding
peripheral insulin infusion experiments, while at the same time peripheral
insulin concentrations were approximately matched. Equal peripheral insulin
concentration resulted in equivalent HGO suppression irrespective of the
portal concentrations. Thus, insulin affects a signal at a peripheral site,
other than alpha-cell, that in turn suppresses hepatic glucose production.
To investigate the nature of this signal, we measured alanine, lactate, and
free fatty acids (FFAs).(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. H. Nelson, R. Basu, C. M. Johnson, R. A. Rizza, and J. M. Miles
Splanchnic Spillover of Extracellular Lipase Generated Fatty Acids in Overweight and Obese Humans
Diabetes,
December 1, 2007;
56(12):
2878 - 2884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Nelson, D. S. Edgerton, R. Basu, J. C. Roesner, A. D. Cherrington, and J. M. Miles
Triglyceride Uptake and Lipoprotein Lipase-Generated Fatty Acid Spillover in the Splanchnic Bed of Dogs
Diabetes,
July 1, 2007;
56(7):
1850 - 1855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Bergman
Orchestration of Glucose Homeostasis: From a Small Acorn to the California Oak
Diabetes,
June 1, 2007;
56(6):
1489 - 1501.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Montonen, R. Jarvinen, P. Knekt, M. Heliovaara, and A. Reunanen
Consumption of Sweetened Beverages and Intakes of Fructose and Glucose Predict Type 2 Diabetes Occurrence
J. Nutr.,
June 1, 2007;
137(6):
1447 - 1454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Kim, M. Ellmerer, E. L. Kirkman, and R. N. Bergman
beta-Cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model
Am J Physiol Endocrinol Metab,
June 1, 2007;
292(6):
E1581 - E1589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Girard
The Inhibitory Effects of Insulin on Hepatic Glucose Production Are Both Direct and Indirect
Diabetes,
December 1, 2006;
55(Supplement_2):
S65 - S69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hu, W. Liu, R. Huang, and X. Zhang
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases
J. Lipid Res.,
September 1, 2006;
47(9):
1908 - 1914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Andreelli, M. Foretz, C. Knauf, P. D. Cani, C. Perrin, M. A. Iglesias, B. Pillot, A. Bado, F. Tronche, G. Mithieux, et al.
Liver Adenosine Monophosphate-Activated Kinase-{alpha}2 Catalytic Subunit Is a Key Target for the Control of Hepatic Glucose Production by Adiponectin and Leptin But Not Insulin
Endocrinology,
May 1, 2006;
147(5):
2432 - 2441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Riddle and D. J. Drucker
Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1
Diabetes Care,
February 1, 2006;
29(2):
435 - 449.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Schernthaner, D. R. Matthews, B. Charbonnel, M. Hanefeld, P. Brunetti, and on Behalf of the Quarter Study Group
Efficacy and Safety of Pioglitazone Versus Metformin in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Randomized Trial
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6068 - 6076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. T. Samuel, Z.-X. Liu, X. Qu, B. D. Elder, S. Bilz, D. Befroy, A. J. Romanelli, and G. I. Shulman
Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease
J. Biol. Chem.,
July 30, 2004;
279(31):
32345 - 32353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Morgan, S. Obici, and L. Rossetti
Hypothalamic Responses to Long-chain Fatty Acids Are Nutritionally Regulated
J. Biol. Chem.,
July 23, 2004;
279(30):
31139 - 31148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Kern, G. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan
Perilipin Expression in Human Adipose Tissue Is Elevated with Obesity
J. Clin. Endocrinol. Metab.,
March 1, 2004;
89(3):
1352 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Camacho, R. R. Pencek, D. B. Lacy, F. D. James, and D. H. Wasserman
Suppression of Endogenous Glucose Production by Mild Hyperinsulinemia During Exercise Is Determined Predominantly by Portal Venous Insulin
Diabetes,
February 1, 2004;
53(2):
285 - 293.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. S. Pankow, B. B. Duncan, M. I. Schmidt, C. M. Ballantyne, D. J. Couper, R. C. Hoogeveen, and S. H. Golden
Fasting Plasma Free Fatty Acids and Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities study
Diabetes Care,
January 1, 2004;
27(1):
77 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Kim, M. Ellmerer, G. W. Van Citters, and R. N. Bergman
Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog
Diabetes,
October 1, 2003;
52(10):
2453 - 2460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-J. Freyse, T. Giessmann, K. J. Petzke, S. Knospe, G. Engel, P. Heinke, C. C. Metges, and W. Siegmund
Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers
Am J Physiol Endocrinol Metab,
July 1, 2003;
285(1):
E54 - E62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Mittendorfer, O. Liem, B. W. Patterson, J. M. Miles, and S. Klein
What Does the Measurement of Whole-Body Fatty Acid Rate of Appearance in Plasma by Using a Fatty Acid Tracer Really Mean?
Diabetes,
July 1, 2003;
52(7):
1641 - 1648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Cleasby, P. A. T. Kelly, B. R. Walker, and J. R. Seckl
Programming of Rat Muscle and Fat Metabolism by in Utero Overexposure to Glucocorticoids
Endocrinology,
March 1, 2003;
144(3):
999 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guldstrand, B. Ahren, and U. Adamson
Improved beta -cell function after standardized weight reduction in severely obese subjects
Am J Physiol Endocrinol Metab,
March 1, 2003;
284(3):
E557 - E565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S Elliott, N. L Keim, J. S Stern, K. Teff, and P. J Havel
Fructose, weight gain, and the insulin resistance syndrome
Am. J. Clinical Nutrition,
November 1, 2002;
76(5):
911 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gupta, H. Sandhu, T. Goh, K. Shah, S. R. Wiesenthal, H. Yoshii, V. Chong, T. K. T. Lam, C. A. Haber, W. Williams, et al.
Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia
Am J Physiol Endocrinol Metab,
November 1, 2002;
283(5):
E1002 - E1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Singhal, A. Caumo, P. E. Carey, C. Cobelli, and R. Taylor
Regulation of endogenous glucose production after a mixed meal in type 2 diabetes
Am J Physiol Endocrinol Metab,
August 1, 2002;
283(2):
E275 - E283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Boden, P. Cheung, T. P. Stein, K. Kresge, and M. Mozzoli
FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis
Am J Physiol Endocrinol Metab,
July 1, 2002;
283(1):
E12 - E19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sun, S. Liu, S. Ferguson, L. Wang, P. Klepcyk, J. S. Yun, and J. E. Friedman
Phosphoenolpyruvate Carboxykinase Overexpression Selectively Attenuates Insulin Signaling and Hepatic Insulin Sensitivity in Transgenic Mice
J. Biol. Chem.,
June 21, 2002;
277(26):
23301 - 23307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev.,
April 1, 2002;
23(2):
201 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Mittelman, G. W. Van Citters, E. L. Kirkman, and R. N. Bergman
Extreme Insulin Resistance of the Central Adipose Depot In Vivo
Diabetes,
March 1, 2002;
51(3):
755 - 761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Dea, M. Hamilton-Wessler, M. Ader, D. Moore, L. Schaffer, M. Loftager, A. Volund, and R. N. Bergman
Albumin Binding of Acylated Insulin (NN304) Does Not Deter Action to Stimulate Glucose Uptake
Diabetes,
March 1, 2002;
51(3):
762 - 769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Meigs, C. I. M. Panhuysen, R. H. Myers, P. W.F. Wilson, and L. A. Cupples
A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study
Diabetes,
March 1, 2002;
51(3):
833 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Sumner, N. M. Farmer, C. S. Cochran, N. G. Sebring, K. Vanevski, J. C. Reynolds, A. Premkumar, and R. C. Boston
Obese Premenopausal African-American Women With Normal and Impaired Glucose Tolerance Have a Similar Degree of Insulin Resistance but Differ in {beta}-Cell Function
Diabetes Care,
November 1, 2001;
24(11):
1978 - 1983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fosgerau, S. D. Mittelman, A. Sunehag, M. K. Dea, K. Lundgren, and R. N. Bergman
Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model
Am J Physiol Endocrinol Metab,
August 1, 2001;
281(2):
E375 - E383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Frias, G. B. Macaraeg, J. Ofrecio, J. G. Yu, J. M. Olefsky, and Y. T. Kruszynska
Decreased Susceptibility to Fatty Acid-Induced Peripheral Tissue Insulin Resistance in Women
Diabetes,
June 1, 2001;
50(6):
1344 - 1350.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. E. Kelley and B. H. Goodpaster
Skeletal Muscle Triglyceride: An aspect of regional adiposity and insulin resistance
Diabetes Care,
May 1, 2001;
24(5):
933 - 941.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. E. Bizeau, J. S. Thresher, and M. J. Pagliassotti
A high-sucrose diet increases gluconeogenic capacity in isolated periportal and perivenous rat hepatocytes
Am J Physiol Endocrinol Metab,
May 1, 2001;
280(5):
E695 - E702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. D. Oakes, P. G. Thalén, S. M. Jacinto, and B. Ljung
Thiazolidinediones Increase Plasma-Adipose Tissue FFA Exchange Capacity and Enhance Insulin-Mediated Control of Systemic FFA Availability
Diabetes,
May 1, 2001;
50(5):
1158 - 1165.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Way, W. W. Harrington, K. K. Brown, W. K. Gottschalk, S. S. Sundseth, T. A. Mansfield, R. K. Ramachandran, T. M. Willson, and S. A. Kliewer
Comprehensive Messenger Ribonucleic Acid Profiling Reveals That Peroxisome Proliferator-Activated Receptor {{gamma}} Activation Has Coordinate Effects on Gene Expression in Multiple Insulin-Sensitive Tissues
Endocrinology,
March 1, 2001;
142(3):
1269 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Mittelman and R. N. Bergman
Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin
Am J Physiol Endocrinol Metab,
September 1, 2000;
279(3):
E630 - E637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Axelsen, P. Lonnroth, R. A. Lenner, M.-R. Taskinen, and U. Smith
Suppression of nocturnal fatty acid concentrations by bedtime carbohydrate supplement in type 2 diabetes: effects on insulin sensitivity, lipids, and glycemic control
Am. J. Clinical Nutrition,
May 1, 2000;
71(5):
1108 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ritz-Laser, P. Meda, I. Constant, N. Klages, A. Charollais, A. Morales, C. Magnan, A. Ktorza, and J. Philippe
Glucose-Induced Preproinsulin Gene Expression Is Inhibited by the Free Fatty Acid Palmitate
Endocrinology,
September 1, 1999;
140(9):
4005 - 4014.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. L. Teff and R. R. Townsend
Early phase insulin infusion and muscarinic blockade in obese and lean subjects
Am J Physiol Regulatory Integrative Comp Physiol,
July 1, 1999;
277(1):
R198 - R208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Sindelar, K. Igawa, C. A. Chu, J. H. Balcom, D. W. Neal, and A. D. Cherrington
Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog
Am J Physiol Endocrinol Metab,
April 1, 1999;
276(4):
E806 - E813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. A. Fonseca, T. R. Valiquett, S. M. Huang, M. N. Ghazzi, and R. W. Whitcomb
Troglitazone Monotherapy Improves Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled Study
J. Clin. Endocrinol. Metab.,
September 1, 1998;
83(9):
3169 - 3176.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, M. Vranic, and A. Giacca
Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans
Am J Physiol Endocrinol Metab,
July 1, 1998;
275(1):
E177 - E186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. McCall, S. R. Wiesenthal, Z. Q. Shi, K. Polonsky, and A. Giacca
Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs
Am J Physiol Endocrinol Metab,
February 1, 1998;
274(2):
E346 - E356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. O. Deems, R. C. Anderson, and J. E. Foley
Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeys
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 1998;
274(2):
R524 - R528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ranheim, C. Dumke, K. L. Schueler, G. D. Cartee, and A. D. Attie
Interaction Between BTBR and C57BL/6J Genomes Produces an Insulin Resistance Syndrome in (BTBR x C57BL/6J) F1 Mice
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1997;
17(11):
3286 - 3293.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Giacca, S. J. Fisher, R. H. McCall, Z. Q. Shi, and M. Vranic
Direct and Indirect Effects of Insulin in Suppressing Glucose Production in Depancreatized Dogs: Role of Glucagon
Endocrinology,
March 1, 1997;
138(3):
999 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|